Rubicon Point Partners acquired the 201,078-square-foot Shockwave Medical headquarters campus in Santa Clara, California, fully leased to Shockwave Medical, a Johnson & Johnson subsidiary. This purchase marks the start of a billion-dollar investment plan focused on high-quality, mission-critical real estate in dynamic West Coast markets. Located in Silicon Valley near tech giants like Apple and NVIDIA, the campus serves as Shockwave's global HQ and R&D center, supporting innovation in cardiovascular medical devices. The deal reflects Rubicon Point's strategy to invest in supply-constrained, innovation-driven markets with strong long-term demand.
Johnson & Johnson shares increased 2.58% recently, supported by strong oncology sales and a solid Q1 earnings beat with $24.06 billion revenue and $2.70 EPS. The company raised its full-year revenue and EPS guidance, driven by growth in drugs like DA...
A 66-year-old retiree in Pennsylvania aimed to generate $55,000 annually from a $1.1 million portfolio but lost $2,400 in tax savings because her IRA automatically reinvested dividends shortly after she sold shares at a loss. This triggered the IRS w...
Nanobiotix and Johnson & Johnson presented early Phase 2 trial data for JNJ-1900 (NBTXR3), a novel nanoradioenhancer, in stage 3 inoperable non-small cell lung cancer (NSCLC). The treatment, combined with chemoradiotherapy and durvalumab, showed an o...
The healthcare sector, particularly healthcare equipment, is currently undervalued compared to historical averages. The iShares U.S. Pharmaceuticals ETF (IHE) has notably outperformed the broader healthcare ETF XLV by 27% over the past year, driven l...
A global survey of 817 bladder cancer patients and 802 urologists reveals that standard treatments like bladder removal surgery and BCG therapy significantly harm patients' physical, emotional, and mental health. Over 90% of patients report negative ...
